Repligen Corporation (RGEN) stock analysis

In our weekly check, Repligen Corporation is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 4, red flags: 6.

About Repligen Corporation

Repligen Corporation is a Healthcare company (Medical Instruments & Supplies) based in the United States, listed on NASDAQ as RGEN.

What our checks show for RGEN

Red flags

Warning signs

Strengths

Similar companies

AVTR · COO · ATR · BAX · SOLV · BLCO

Questions

What grade does Repligen Corporation (RGEN) have?

In our weekly check, Repligen Corporation is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 4, red flags: 6. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of RGEN stock?

This week's biggest flags for Repligen Corporation: Margins falling, Gross margin falling, Weak EPS growth. In total 10 of 22 checks show a warning or a red flag.

What does Repligen Corporation do?

Repligen Corporation is a Healthcare company (Medical Instruments & Supplies) based in the United States, listed on NASDAQ as RGEN.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis